4.8 Article

Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike

Journal

ELIFE
Volume 11, Issue -, Pages -

Publisher

eLIFE SCIENCES PUBL LTD
DOI: 10.7554/eLife.75433

Keywords

virus entry; protein dynamics; single-molecule biophysics; Viruses

Categories

Funding

  1. UMass Chan Medical School COVID-19 Pandemic Relief Fund
  2. National Institutes of Health [R37AI147868, R01AI148784, K22CA241362]
  3. Evergrande COVID-19 Response Fund
  4. Massachusetts Consortium on Pathogen Readiness
  5. Worcester Foundation for Biomedical Research

Ask authors/readers for more resources

This study reveals the effects of ACE2 and antibody binding on the conformational dynamics of SARS-CoV-2 spike protein. The D614G mutation and antibodies targeting diverse epitopes are found to modulate the energetics of the receptor-binding domain (RBD) position and enhance ACE2 binding. These findings offer insights into the development of therapeutic antibody cocktails.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects cells through binding to angiotensin-converting enzyme 2 (ACE2). This interaction is mediated by the receptor-binding domain (RBD) of the viral spike (S) glycoprotein. Structural and dynamic data have shown that S can adopt multiple conformations, which controls the exposure of the ACE2-binding site in the RBD. Here, using single-molecule Forster resonance energy transfer (smFRET) imaging, we report the effects of ACE2 and antibody binding on the conformational dynamics of S from the Wuhan-1 strain and in the presence of the D614G mutation. We find that D614G modulates the energetics of the RBD position in a manner similar to ACE2 binding. We also find that antibodies that target diverse epitopes, including those distal to the RBD, stabilize the RBD in a position competent for ACE2 binding. Parallel solution-based binding experiments using fluorescence correlation spectroscopy (FCS) indicate antibody-mediated enhancement of ACE2 binding. These findings inform on novel strategies for therapeutic antibody cocktails.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available